United States · Series A startup

Who invested in Tenvie Therapeutics

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$200Mraised across 1 round since 2025, from 1 source

Latest round
Series A, $200MJan 2025
Investors
2
See who backed them

The rounds

  1. Jan 2025
    Series A$200M

    Source recorded

Founders and team

From Tenvie Therapeutics's own website: 14 on the team.

  • Tony EstradaPresident & Chief Executive Officer
  • Bill AverySenior Vice President, Non-Clinical Safety & Developmental Sciences
  • Caitlin McLaughlinVice President, Finance & Accounting
  • Filomene MorrisonVice President, Finance & Accounting
  • Katrina LexaVice President, Technology & Computational Science
  • Min LiuVice President, Technology & Computational Science
  • Patty AverillVice President, Clinical Operations
  • Ryan TakahashiVice President, DMPK & Clinical Pharmacology
  • Steven KatesSenior Vice President, Regulatory & Quality Affairs
  • Sulynn BarnesSenior Vice President, Operations & People
  • Don O’SullivanChief Business Officer
  • Tanya FischerChief Medical Officer
  • Matt LaughlinSenior Director, Data Management
  • Tim LehmbergSenior Director, Data Management

Everyone who backed them

MubadalaPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Tenvie Therapeutics

Who invested in Tenvie Therapeutics?

Tenvie Therapeutics's investors include ARCH Venture Partners and Mubadala.

How much has Tenvie Therapeutics raised?

Tenvie Therapeutics has raised $200M across 1 round since 2025.

When did Tenvie Therapeutics last raise?

Tenvie Therapeutics's most recent round was a Series A of $200M in Jan 2025.

What was Tenvie Therapeutics's biggest round?

Its most recent round, $200M in Jan 2025, is also its largest on record.

Who backed Tenvie Therapeutics first?

Tenvie Therapeutics's first round on record, in Jan 2025, was backed by ARCH Venture Partners and Mubadala.

What stage is Tenvie Therapeutics at?

Tenvie Therapeutics's latest named round is a Series A, in Jan 2025.

Where is Tenvie Therapeutics based?

Tenvie Therapeutics is based in the United States.

Companies like Tenvie Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.